-+ 0.00%
-+ 0.00%
-+ 0.00%

LIB THERAPEUTICS AND SUN PHARMA ANNOUNCE GLOBAL LICENSING, COMMERCIALIZATION AND MANUFACTURING AGREEMENT FOR LERODALCIBEP, A NOVEL PCSK9 INHIBITOR, EX-US AND CHINA; LERODALCIBEP (LYROKAUL®) APPROVED IN THE EU

Reuters·09/28/2026 12:02:51

Veuillez vous connecter pour afficher les détails des actualités